Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
NCT03253705 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-04-24
Summary
Background:
This study is designed to provide samples to help us study the genes your blood cells are making as well as the proteins, sugars, fats, vitamins and other metabolites found in your blood or urine. Blood samples may also be collected to make special cells. These are called induced pluripotent stem cells or iPSCs. Pluripotent stem cells are cells that can be converted into any type of cell. Researchers want to study in the lab iPSCs that are derived from blood samples.
Objective:
To collect samples to help study genes, proteins, sugars, fats, vitamins, and other metabolites found in blood or urine.
Eligibility:
Healthy volunteers and patients ages 18 and older
Design:
First-time research study participants at NIH will have an initial visit for this study that should last no more than 1 hour. All other visits should last 20 30 minutes.
Participants will undergo a limited history and physical exam.
Participants may have routine blood and urine tests.
If participants are giving a blood sample, they must have a hemoglobin level checked in the past 12 months to make sure it is safe for them to give a blood sample for research.
Participants may have a venous blood collection. They may do this at several visits. They will lie on a recliner or couch or sit in a chair. A needle will be placed into a vein in the hand or arm, using sterile techniques. Blood will be withdrawn into multiple syringes or tubes.
Participants may be asked to provide urine in an appropriate container...
Conditions
- Endothelial Dysfunction
- Inflammation in Cardiopulmonary and Vascular Disease States
- Healthy Volunteers
Sponsors & Collaborators
-
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
Michael A Solomon, M.D. · National Institutes of Health Clinical Center (CC)
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-14
- Primary Completion
- 2027-08-01
- Completion
- 2027-08-01
Countries
- United States
Study Locations
More Related Trials
-
Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
NCT01071577 ·Status: TERMINATED
-
A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency
NCT00655707 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
NCT00628199 ·Status: ENROLLING_BY_INVITATION
-
Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
NCT03321942 ·Status: UNKNOWN ·Phase: NA
-
Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
NCT05647213 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Exercise on Stem Cell Mobilization and Heart Function in Patients Undergoing Cardiac Rehabilitation
NCT00053456 ·Status: COMPLETED
-
Effect of Exosomes Derived From Red Blood Cell Units on Platelet Function and Blood Coagulation
NCT02594345 ·Status: COMPLETED ·Phase: NA
-
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
NCT07332338 ·Status: AVAILABLE
-
Human Umbilical Cord Blood (RegeneCyte) Infusion in Patients with Post-COVID Syndrome
NCT05682560 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Post-COVID Condition
NCT07184385 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
NCT02266394 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Circulating Levels of Adult Stem Cells in the Peripheral Blood of Patients With Acute Decompensated Heart Failure and Following Stabilization, in Comparison With Healthy Volunteers
NCT01027403 ·Status: COMPLETED
-
Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iPSC-IEM)
NCT04097275 ·Status: UNKNOWN
-
Stem Cell Collection for Adult Volunteers
NCT00033774 ·Status: TERMINATED
-
Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia
NCT01867190 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases
NCT06416709 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study
NCT03132337 ·Status: COMPLETED
-
In Vivo Tracking of USPIO Labeled MSC in the Heart
NCT03651791 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases
NCT03172507 ·Status: COMPLETED
-
Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes
NCT03514537 ·Status: SUSPENDED ·Phase: NA
-
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
NCT06364150 ·Status: RECRUITING ·Phase: PHASE3
-
Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia
NCT01595776 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19
NCT04780685 ·Status: UNKNOWN ·Phase: PHASE2
-
Cardiomyopathy Tissue Bank in a Cancer Population
NCT00500734 ·Status: UNKNOWN
-
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
NCT04533464 ·Status: RECRUITING ·Phase: PHASE2